Literature DB >> 18160998

Association of an intronic haplotype of the LIPC gene with hyperalphalipoproteinemia in two independent populations.

Hiroshi Iijima1,2, Mitsuru Emi3,4, Manabu Wada1, Makoto Daimon1, Sayumi Toriyama1,2, Satoru Koyano1,2, Hidenori Sato1,2, Paul N Hopkins5, Steven C Hunt5, Isao Kubota6, Sumio Kawata7, Takeo Kato8.   

Abstract

Hepatic lipase (HL) plays a major role in the regulation of plasma lipids. Several groups seeking to find association between the gene encoding HL (LIPC) and plasma concentrations of high-density lipoprotein cholesterol (HDLc) using various methods and populations have reported conflicting results. We have approached the problem of demonstrating a relationship between the LIPC locus and HDLc by means of haplotype association using four single nucleotide polymorphisms (SNPs) (rs12594375G/A, rs8023503C/T, rs4775047C/T, and rs11634134T/A) located in intron 1 of the LIPC gene in two independent Japanese populations consisting of 2,970 and 1,638 individuals, respectively. Significant association between hyperalphalipoproteinemia and a specific haplotype in this intron was detected in both populations. When HDLc levels among the three haplotypic categories were analyzed [haplotype rs8023503C/rs12594375G (haplotype-1; H1) homozygotes (H1H1), haplotype rs8023503T/rs12594375A (haplotype-2; H2) homozygotes (H2H2), and heterozygotes (H1H2)], HDLc levels were lowest among H1H1 [mean +/- standard error (SE) = 58.4 +/- 0.4 mg/dl], highest among H2H2 (62.5 +/- 0.8 mg/dl), and intermediate among H1H2 (59.2 +/- 0.4 mg/dl) (P = 0.00011), indicating that H2 haplotype elevates plasma HDLc levels. This association was validated in the second population (n = 1,638) (P = 0.00070). The results provide convincing evidence that the LIPC locus influences HDL metabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160998     DOI: 10.1007/s10038-007-0236-0

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  45 in total

1.  Score tests for association between traits and haplotypes when linkage phase is ambiguous.

Authors:  Daniel J Schaid; Charles M Rowland; David E Tines; Robert M Jacobson; Gregory A Poland
Journal:  Am J Hum Genet       Date:  2001-12-27       Impact factor: 11.025

2.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

3.  Polymorphism of HL +1075C, but not -480T, is associated with plasma high density lipoprotein cholesterol and apolipoprotein AI in men of a Chinese population.

Authors:  Ding Z Fang; Bing W Liu
Journal:  Atherosclerosis       Date:  2002-04       Impact factor: 5.162

4.  A hepatic lipase gene mutation associated with heritable lipolytic deficiency.

Authors:  R A Hegele; C Vezina; S Moorjani; P J Lupien; C Gagne; L D Brun; J A Little; P W Connelly
Journal:  J Clin Endocrinol Metab       Date:  1991-03       Impact factor: 5.958

5.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

6.  In vivo evidence for both lipolytic and nonlipolytic function of hepatic lipase in the metabolism of HDL.

Authors:  K A Dugi; M J Amar; C C Haudenschild; R D Shamburek; A Bensadoun; R F Hoyt; J Fruchart-Najib; Z Madj; H B Brewer; S Santamarina-Fojo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-03       Impact factor: 8.311

7.  Promoter polymorphisms of hepatic lipase gene influence HDL(2) but not HDL(3) in African American men: CARDIA study.

Authors:  S H Juo; Z Han; J D Smith; L Colangelo; K Liu
Journal:  J Lipid Res       Date:  2001-02       Impact factor: 5.922

8.  The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B : European Atherosclerosis Research Study (EARS) II.

Authors:  H Jansen; G Chu; C Ehnholm; J Dallongeville; V Nicaud; P J Talmud
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-02       Impact factor: 8.311

9.  Visceral obesity attenuates the effect of the hepatic lipase -514C>T polymorphism on plasma HDL-cholesterol levels in French-Canadian men.

Authors:  Julie St-Pierre; Isabelle Miller-Felix; Marie-Eve Paradis; Jean Bergeron; Benoît Lamarche; Jean-Pierre Després; Daniel Gaudet; Marie-Claude Vohl
Journal:  Mol Genet Metab       Date:  2003-01       Impact factor: 4.797

10.  Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men. Genetic and pharmacological evidence.

Authors:  S M Grundy; G L Vega; J D Otvos; D L Rainwater; J C Cohen
Journal:  J Lipid Res       Date:  1999-02       Impact factor: 5.922

View more
  2 in total

Review 1.  Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.

Authors:  Eva Boes; Stefan Coassin; Barbara Kollerits; Iris M Heid; Florian Kronenberg
Journal:  Exp Gerontol       Date:  2008-11-17       Impact factor: 4.032

2.  Genetic variation in phospholipid transfer protein modulates lipoprotein profiles in hyperalphalipoproteinemia.

Authors:  Mary B Engler; Clive R Pullinger; Mary J Malloy; Yanina Natanzon; Medha V Kulkarni; James Song; Celeste Eng; Jaarko Huuskonen; Christopher Rivera; Annie Poon; Matt Bensley; Amy Sehnert; Christian Zellner; John Kane; Bradley E Aouizerat
Journal:  Metabolism       Date:  2008-12       Impact factor: 8.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.